STUART HENSLEY: Open Payments
NPI 1205617305 · DELMAR, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 45 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,836 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $305 |
| Amgen Inc. | 3 | $152 |
| Lilly USA, LLC | 5 | $105 |
| Lundbeck LLC | 4 | $94 |
| Exact Sciences Corporation | 3 | $84 |
| Paratek Pharmaceuticals, Inc. | 3 | $70 |
| Aimmune Therapeutics, Inc. | 2 | $65 |
| Novo Nordisk Inc | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 3 | $41 |
| GlaxoSmithKline, LLC. | 2 | $40 |
Products named: FARXIGA, REPATHA, AIRSUPRA, REXULTI, MOUNJARO, The Cologuard Plus Collection Kit, NUZYRA, VOWST.
Industry payments across DE — which companies pay providers there.
